Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?
作者信息
Lang D
出版信息
Heart. 2002 Apr;87(4):316-7. doi: 10.1136/heart.87.4.316.
Abstract
摘要
相似文献
1
Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?心脏肥大与氧化应激：是信念的飞跃还是残酷的现实？
Heart. 2002 Apr;87(4):316-7. doi: 10.1136/heart.87.4.316.
2
Oxidative stress and cardiac hypertrophy: a review.氧化应激与心肌肥厚：综述。
Toxicol Mech Methods. 2012 Jun;22(5):359-66. doi: 10.3109/15376516.2012.666650. Epub 2012 Mar 20.
3
Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story.氧化应激在甲状腺激素诱导的心肌细胞肥大及相关心脏功能障碍中的作用：一个未被揭示的故事
Oxid Med Cell Longev. 2015;2015:854265. doi: 10.1155/2015/854265. Epub 2015 Jun 4.
4
5
Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction.氧化应激在勃起功能障碍病理生理机制中的作用。
J Androl. 2006 May-Jun;27(3):335-47. doi: 10.2164/jandrol.05136. Epub 2005 Dec 8.
6
The role of oxidative stress in atherosclerosis.氧化应激在动脉粥样硬化中的作用。
Hellenic J Cardiol. 2009 Sep-Oct;50(5):402-9.
7
Role of oxidative stress in cardiac hypertrophy and remodeling.氧化应激在心肌肥厚和重塑中的作用。
Hypertension. 2007 Feb;49(2):241-8. doi: 10.1161/01.HYP.0000254415.31362.a7. Epub 2006 Dec 26.
8
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis.心动过速增强心脏氧化应激及其在心脏肥大和纤维化中的关键作用。
J Hypertens. 2006 Oct;24(10):2057-69. doi: 10.1097/01.hjh.0000244956.47114.c1.
9
Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.采用全谱抗氧化治疗和辅助策略预防心脏重构和心房颤动的实用方法。
Med Hypotheses. 2010 Aug;75(2):141-7. doi: 10.1016/j.mehy.2009.12.025. Epub 2010 Jan 18.
10
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.塞利洛尔是一种血管舒张性β受体阻滞剂，可抑制压力超负荷诱导的心肌肥大，并通过一氧化氮依赖性机制预防小鼠发生心力衰竭。
Circulation. 2004 Aug 10;110(6):692-9. doi: 10.1161/01.CIR.0000137831.08683.E1. Epub 2004 Jul 19.
引用本文的文献
1
The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts.终末期人类衰竭心脏中心肌肌钙蛋白I和肌球蛋白结合蛋白C的S-谷胱甘肽化与磷酸化之间的相互作用
Antioxidants (Basel). 2021 Jul 16;10(7):1134. doi: 10.3390/antiox10071134.
2
Molecular biomarkers in cardiac hypertrophy.心肌肥厚中的分子生物标志物。
J Cell Mol Med. 2019 Mar;23(3):1671-1677. doi: 10.1111/jcmm.14129. Epub 2019 Jan 16.
3
Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1.小鼠Sirt3通过使叉头框蛋白O1（FoxO1）去乙酰化，促进血管紧张素II诱导的心肌肥大中的自噬。
Oncotarget. 2016 Dec 27;7(52):86648-86659. doi: 10.18632/oncotarget.13429.
4
From sirtuin biology to human diseases: an update.从长寿蛋白生物学到人类疾病：最新进展。
J Biol Chem. 2012 Dec 14;287(51):42444-52. doi: 10.1074/jbc.R112.402768. Epub 2012 Oct 18.
5
Mitochondrial SIRT3 and heart disease.线粒体 SIRT3 与心脏病。
Cardiovasc Res. 2010 Nov 1;88(2):250-6. doi: 10.1093/cvr/cvq250. Epub 2010 Aug 4.
6
Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes.血红素加氧酶-1抑制促氧化剂诱导的HL-1心肌细胞肥大。
Exp Biol Med (Maywood). 2009 May;234(5):582-94. doi: 10.3181/0810-RM-312. Epub 2009 Feb 25.
7
Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy.氧化应激与心脏病：心脏功能障碍、营养与基因治疗。
Curr Hypertens Rep. 2003 Jun;5(3):215-20. doi: 10.1007/s11906-003-0023-z.
本文引用的文献
1
Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.艾地苯醌与弗里德赖希共济失调中减轻的心脏肥大
Heart. 2002 Apr;87(4):346-9. doi: 10.1136/heart.87.4.346.
2
Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase.心脏肥大时内皮对心室舒张调节功能受损：活性氧和NADPH氧化酶的作用
Circulation. 2001 Dec 11;104(24):2967-74. doi: 10.1161/hc4901.100382.
3
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.他汀类药物作为预防心肌细胞肥大的抗氧化疗法。
J Clin Invest. 2001 Nov;108(10):1429-37. doi: 10.1172/JCI13350.
4
Signal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach.心脏肥大中的信号转导——利用转基因方法剖析代偿性与病理性途径。
Curr Opin Pharmacol. 2001 Apr;1(2):134-40. doi: 10.1016/s1471-4892(01)00029-7.
5
Disabled early recruitment of antioxidant defenses in Friedreich's ataxia.弗里德赖希共济失调中抗氧化防御的早期募集受损。
Hum Mol Genet. 2001 Sep 15;10(19):2061-7. doi: 10.1093/hmg/10.19.2061.
6
Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.血管紧张素转换酶抑制剂和血管紧张素Ⅱ1型受体拮抗剂对大鼠慢性一氧化氮合成抑制所致心脏重塑的亚细胞差异作用
Hypertension. 2001 Sep;38(3):404-11. doi: 10.1161/01.hyp.38.3.404.
7
17beta-estradiol attenuates the development of pressure-overload hypertrophy.17β-雌二醇可减轻压力超负荷肥大的发展。
Circulation. 2001 Sep 18;104(12):1419-23. doi: 10.1161/hc3601.095577.
8
Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs.
Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1704-10. doi: 10.1152/ajpheart.2001.281.4.H1704.
9
Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.在没有心脏功能障碍和肥大的情况下，弗里德赖希共济失调患者的心脏能量代谢异常：一项活体31P磁共振波谱研究。
Cardiovasc Res. 2001 Oct;52(1):111-9. doi: 10.1016/s0008-6363(01)00357-1.
10
Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency.补充维生素E对维生素E缺乏型共济失调患者的影响。
Eur J Neurol. 2001 Sep;8(5):477-81. doi: 10.1046/j.1468-1331.2001.00273.x.
Zotero 插件